{"id":3703,"date":"2022-03-31T12:48:57","date_gmt":"2022-03-31T11:48:57","guid":{"rendered":"https:\/\/wordpress-759507-4181889.cloudwaysapps.com\/?page_id=3703"},"modified":"2026-05-21T13:08:16","modified_gmt":"2026-05-21T11:08:16","slug":"company-management","status":"publish","type":"page","link":"https:\/\/chemotech.se\/?page_id=3703","title":{"rendered":"Company Management"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Company Management<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Extensive expertise<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

ChemoTech has a very competent management and Board of Directors with extensive expertise and substantial experience of medical research and clinical work, as well as of the international healthcare industry.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Mohan Frick\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

CEO, Co-Founder and Co-Inventor TSE\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Born 1974. Member of the Board of Directors and CEO since 2015<\/div>
\u00a0<\/div>
Not independent in relation to the Company and, being the Company\u00b4s largest shareholder, not independent in relation to major shareholders.<\/div>
\u00a0<\/div>

Education and experience:<\/em>\u00a0BA, Marketing, Management, Lund University. 20 years\u2019 experience as market manager, sales manager and Board member of life science companies. Has among other things held positions in Arjo AB, Getinge, Navigator Communications, Insulution AB, OnMeD and SYSMEX.<\/p>

Current assignments:<\/em>\u00a0Chairman of Scandinavian MediTech (Indian subsidiary), Fricks Property & Equity Invest AB.<\/p><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 1 285 000 A-shares, 1 732 346 B-shares, 300 000 warrants, direct or via company.\u00a0<\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Robin Sukhia\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Chairman of the Board of Directors\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Born 1973. Chairman of the Board of Directors since 2020<\/p>

Independent of the Company and independent of major shareholders.<\/p>

Education and experience<\/em>: B.Sc. in Business Administration from the State University of New York. Robin Sukhia has worked with India since 1996. Through a Swedish Venture Capital firm, he was one of the pioneers in northern Europe to invest in India. He has held board positions in India and Sweden since 2005.<\/p>

Current assignments<\/em>: \u00a0Secretary General and CEO of the Sweden-India Business Council (SIBC) since 2005, which he has built to become one of the most active and prominent bilateral business councils in the world. He has co-founded several new initiatives in SIBC, including a think-tank. He runs the secretariat to ISBLRT \u2013 India Sweden Business Leaders\u2019 Roundtable, which carries nearly 40 of the most senior CEOs and Chairs in Sweden. He also sits on the Investment Committee of the AI and Robotics Park (ARTPARK) Innovation program, housed at the Indian Institute of Science in Bengaluru, India.<\/p><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 100 984 B-shares and 200 000 warrants.<\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Rolf Ehrnstr\u00f6m\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Member of the Board of Directors\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Born 1953. Member of the Board of Directors since 2020.<\/p>

Independent of the Company and independent of major shareholders.<\/p>

E<\/em>ducation and experience:<\/em>\u00a0Royal Institute of Technology; M.Sc. in Biochemistry & Biotechnology. Extensive experience from Life Science Industry. Scientific and Product Development management roles in LKB\/Pharmacia Biotech\/Amersham-Pharmacia Biotech. Co-founder and VP R&D of Gyros AB, CVP\/CSO of Dako-Agilent A\/S, Boardmember of Biomonitor A\/S.<\/p>

Current assignments:<\/em> Boardmember of APLEX bio AB, Boardmember of Lynsight Diagnostics Oy, Boardmember of Gradientech AB, Boardmember of Fluimedix A\/S, CEO and owner of Reomics AB, Partner in Ventac Partners.<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 92 617 B-shares and 150 000 warrants direct or via company.<\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Bengt Engstr\u00f6m\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Member of the Board of Directors\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Born 1953. Member of the Board of Directors since 2020.<\/p>

Independent of the Company and independent of major shareholders.<\/p>

E<\/em>ducation and experience:\u00a0<\/em>Degree from Royal Institute of Technology (KTH) in Stockholm. Formerly President Whirlpool Europe, CEO Duni AB, President Fujitsu Nordic and Director at Bofors AB.<\/p>

Current assignments:\u00a0<\/em>Chairman of Nordic Flanges AB. Board member of Directors of Bure Equity AB, Scanfil OY, ScandiNova Systems AB, KTH Executive School AB, Real Holding AB. CEO of BEngstr\u00f6m AB and BEngstr\u00f6m F\u00f6rvaltning AB.<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 1 084 955 B-shares and 150 000 warrants via company.<\/span><\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Amitbir Singh Banga<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Member of the Board of Directors\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Born 1993. Member of the Board of Directors since 2026.<\/p>

Independent in relation to the Company and independent of major shareholders.<\/p>

Education and Experience<\/em>: Bachelor of Commerce at University of Delhi, Post Graduate Diploma in Business Administration at Annamalai University, Master of Science in Finance at W.P. Carey School of Business at Arizona State University.<\/p>

Current Assignment<\/em>:\u00a0 Director in Victura Technologies Pvt. Ltd. Director in Grand Prix Engineering Pvt. Ltd. Director in Cutting Edge Tecknologies.<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 900 000 shares and 0 warrants.<\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ann Ohlsson\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Head of Finance<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Born 1966. Management since 2020.<\/p>

Education and experience<\/em>: Studies in economics at Lund University and Malm\u00f6 University. 35 years of experience, in various positions within finance departments in several companies of various sizes, for example, Safegate International AB, KPMG and Accountor. Experience as a consultant from, amongst others, Massive Entertainment and Modity Energy Trading via own company.<\/p>

Current assignments: Owner and CEO at R\u00f6nneholm Management AB<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holds 20 000 B-shares and 70 000 warrants.\u00a0<\/p>

On LinkedIn<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our Products<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Read more<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

News & Press Releases<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Read more<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Get in touch<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Are you interested in our products?<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our team is here to help with any questions about our products, patents or anything else you may need help with.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Contact us<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Company Management Extensive expertise ChemoTech has a very competent management and Board of Directors with extensive expertise and substantial experience of medical research and clinical work, as well as of the international healthcare industry. Mohan Frick CEO, Co-Founder and Co-Inventor TSE Born 1974. Member of the Board of Directors and CEO since 2015\u00a0Not independent in […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-3703","page","type-page","status-publish","hentry"],"yoast_head":"\nCompany Management - ChemoTech[Staging]<\/title>\n<meta name=\"description\" content=\"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Company Management - ChemoTech[Staging]\" \/>\n<meta property=\"og:description\" content=\"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemotech.se\/?page_id=3703\" \/>\n<meta property=\"og:site_name\" content=\"ChemoTech[Staging]\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T11:08:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemotech.se\/staging\/wp-content\/uploads\/2022\/04\/profile-default.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703\",\"url\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703\",\"name\":\"Company Management - ChemoTech[Staging]\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemotech.se\\\/staging\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/profile-default.jpg\",\"datePublished\":\"2022-03-31T11:48:57+00:00\",\"dateModified\":\"2026-05-21T11:08:16+00:00\",\"description\":\"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chemotech.se\\\/?page_id=3703\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703#primaryimage\",\"url\":\"https:\\\/\\\/chemotech.se\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/profile-default.jpg\",\"contentUrl\":\"https:\\\/\\\/chemotech.se\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/profile-default.jpg\",\"width\":500,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/?page_id=3703#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chemotech.se\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Company Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/#website\",\"url\":\"https:\\\/\\\/chemotech.se\\\/\",\"name\":\"ChemoTech[Staging]\",\"description\":\"When life science matters\",\"publisher\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chemotech.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/#organization\",\"name\":\"ChemoTech[Staging]\",\"url\":\"https:\\\/\\\/chemotech.se\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/chemotech.se\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/chemotech.se\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/chemotech-logo.png\",\"contentUrl\":\"https:\\\/\\\/chemotech.se\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/chemotech-logo.png\",\"width\":783,\"height\":159,\"caption\":\"ChemoTech[Staging]\"},\"image\":{\"@id\":\"https:\\\/\\\/chemotech.se\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Company Management - ChemoTech[Staging]","description":"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Company Management - ChemoTech[Staging]","og_description":"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.","og_url":"https:\/\/chemotech.se\/?page_id=3703","og_site_name":"ChemoTech[Staging]","article_modified_time":"2026-05-21T11:08:16+00:00","og_image":[{"url":"https:\/\/chemotech.se\/staging\/wp-content\/uploads\/2022\/04\/profile-default.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/chemotech.se\/?page_id=3703","url":"https:\/\/chemotech.se\/?page_id=3703","name":"Company Management - ChemoTech[Staging]","isPartOf":{"@id":"https:\/\/chemotech.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemotech.se\/?page_id=3703#primaryimage"},"image":{"@id":"https:\/\/chemotech.se\/?page_id=3703#primaryimage"},"thumbnailUrl":"https:\/\/chemotech.se\/staging\/wp-content\/uploads\/2022\/04\/profile-default.jpg","datePublished":"2022-03-31T11:48:57+00:00","dateModified":"2026-05-21T11:08:16+00:00","description":"Board of Directors with extensive expertise of medical research and clinical work, as well as of the international healthcare industry.","breadcrumb":{"@id":"https:\/\/chemotech.se\/?page_id=3703#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemotech.se\/?page_id=3703"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/chemotech.se\/?page_id=3703#primaryimage","url":"https:\/\/chemotech.se\/wp-content\/uploads\/2022\/04\/profile-default.jpg","contentUrl":"https:\/\/chemotech.se\/wp-content\/uploads\/2022\/04\/profile-default.jpg","width":500,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/chemotech.se\/?page_id=3703#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chemotech.se\/"},{"@type":"ListItem","position":2,"name":"Company Management"}]},{"@type":"WebSite","@id":"https:\/\/chemotech.se\/#website","url":"https:\/\/chemotech.se\/","name":"ChemoTech[Staging]","description":"When life science matters","publisher":{"@id":"https:\/\/chemotech.se\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemotech.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/chemotech.se\/#organization","name":"ChemoTech[Staging]","url":"https:\/\/chemotech.se\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/chemotech.se\/#\/schema\/logo\/image\/","url":"https:\/\/chemotech.se\/wp-content\/uploads\/2022\/04\/chemotech-logo.png","contentUrl":"https:\/\/chemotech.se\/wp-content\/uploads\/2022\/04\/chemotech-logo.png","width":783,"height":159,"caption":"ChemoTech[Staging]"},"image":{"@id":"https:\/\/chemotech.se\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/pages\/3703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chemotech.se\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3703"}],"version-history":[{"count":179,"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/pages\/3703\/revisions"}],"predecessor-version":[{"id":8238,"href":"https:\/\/chemotech.se\/index.php?rest_route=\/wp\/v2\/pages\/3703\/revisions\/8238"}],"wp:attachment":[{"href":"https:\/\/chemotech.se\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}